BridgeMD
New treatment option for Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay
Official title Effects of a Supervised Rehabilitation Program on Disease Severity in Spastic Ataxias
ClinicalTrials.gov ID: NCT06261424
What this study is testing
- What it's testing
- Spastic ataxias are a group of diseases causing symptoms such as walking difficulties and balance impairments that lead to a high risk of falls. No pharmacological treatments exist to treat these diseases.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 and older
You may be able to join if
- have a confirmed genetic diagnosis of ARSACS or SPG7
- be able to maintain standing position and to transfert
- be authorized by their treating neurologist
- speak French or English
- be able to give informed consent.
You likely can't join if
- have active participation in a rehabilitation program (self-reported information)
- have another condition causing physical limitations
- be uncomfortable in a swimming pool
- be pregnant.
The study team makes the final eligibility decision.
Where it's taking place
- Baie-Saint-Paul, Quebec, Canada
- La Malbaie, Quebec, Canada
- Montreal, Quebec, Canada
- Québec, Quebec, Canada
- Saguenay, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 16 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Baie-Saint-Paul, Quebec, Canada; La Malbaie, Quebec, Canada; Montreal, Quebec, Canada; Québec, Quebec, Canada; Saguenay, Quebec, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.